Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy

PURPOSE: To evaluate the efficacy and safety for mother and child of using intravenous iron isomaltoside (IV-IIM) during pregnancy. METHODS: Using an appointment register, we retrospectively identified all pregnant women who received a single dose of 1000 or 1500 mg IV-IIM in the maternity ward of F...

Descripción completa

Detalles Bibliográficos
Autor principal: Wesström, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181549/
https://www.ncbi.nlm.nih.gov/pubmed/32270330
http://dx.doi.org/10.1007/s00404-020-05509-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181549/
https://www.ncbi.nlm.nih.gov/pubmed/32270330
http://dx.doi.org/10.1007/s00404-020-05509-2

Ejemplares similares